Essity AB is a leading global hygiene and health company operating in the tissue, personal care, and incontinence markets. With iconic brands like TENA, Tork, and Libero, Essity benefits from defensive demand and pricing power. The company is executing a comprehensive cost-saving program and focusing on premium innovation, which should drive margin expansion and earnings growth over the next 12 months.
Investment Thesis: Essity is a classic consumer compounder with a strong competitive moat, high barriers to entry, and recurring revenue streams. The company is undergoing a transformation to improve profitability, including a restructuring program targeting SEK 2 billion in annual savings by 2025. Combined with a shift toward higher-margin products (e.g., professional hygiene, incontinence care) and expansion in emerging markets, we expect mid-single-digit organic growth and meaningful operating leverage. The stock trades at a discount to peers like Kimberly-Clark and Procter & Gamble, offering a compelling risk-reward.
12-Month Catalysts:
- Cost savings program delivering SEK 2 billion in annual savings by 2025, boosting EBIT margins by 100-150 bps.
- Premium product innovation (e.g., TENA Silhouette, Tork EasyCube) driving market share gains and pricing.
- Emerging market expansion, particularly in Asia and Latin America, where Essity has underpenetrated categories.
- Potential portfolio optimization, including divestiture of non-core assets or bolt-on acquisitions.
Key Risks:
- Raw material cost inflation (pulp, energy) could pressure margins if not fully passed through.
- Intense competition from private labels and larger peers could limit pricing power.
Valuation: Essity trades at ~15x forward P/E, a discount to its historical average and peers. With improving margins and mid-single-digit EPS growth, we see potential for multiple expansion to 18x, implying ~20% upside.
Balance Sheet: Essity has a solid investment-grade balance sheet with net debt/EBITDA of ~2.0x, strong free cash flow generation (FCF yield ~5%), and a progressive dividend policy.
Disclaimer: This is not personalized investment advice. Past performance is not indicative of future results. Always conduct your own research before investing.